07:00 , Jun 23, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Protein tyrosine kinase 6 (PTK6)

Cancer INDICATION: Breast cancer Cell culture and mouse studies suggest inhibiting PTK6 could help treat triple-negative breast cancer (TNBC). In breast tumor samples from 60 TNBC patients, PTK6 was expressed in 44 (74%) and highly...
07:00 , Aug 21, 2008 |  BC Innovations  |  Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Breast cancer Protein tyrosine kinase 6 (PTK6; BRK); epidermal growth factor receptor (EGFR; ERBB1; HER1); v-erb-b2 erythroblastic leukemia viral oncogene...